Metabolic Syndrome Ups Odds of ARDS, Death in COVID-19
MONDAY, January 3, 2022 (HealthDay News). In hospitalized patients with COVID-19, having metabolic syndrome is associated with an increased likelihood of acute respiratory distress syndrome (ARDS) and mortality. According to a study released online on December 22. at JAMA Network Open.
Invasive mechanical ventilation, ARDS, and mortality (adjusted odds ratios of 1.32, 1.45, 1.36, and 1.19, respectively). The researchers found metabolic syndrome with increased hospitalization risk of intensive care unit (ICU). The risk of ARDS increased additively with each additional metabolic syndrome criterion (one criterion: 10.4%, two bars: 15.3%, three criteria: 19.3%, four criteria: 24.3%). As well as with long-term hospitalization and length of stay in the intensive care unit (median 8.0 vs. 6.8 days and 7.0 vs. 6.4 days, respectively).
Several authors disclosed financial ties to the pharmaceutical industry.